Platelet Aggregation Devices Market Research Report – Forecast till 2027

Platelet Aggregation Devices Market Trends And Growth Analysis By Product (Systems, Reagents, Consumables And Accessories), Application (Clinical, Research Applications), End User (Hospitals And Clinics, Diagnostic Laboratories, Others)- Forecast Till 2027

ID: MRFR/HC/5981-HCR | February 2021 | Region: Global | 90 pages

Platelet Aggregation Devices Market Scenario


The platelet aggregation devices market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 215.2 million in 2017 and is projected to grow at a CAGR of 20.3% during the forecast period. Platelet aggregation is the process wherein platelets are clumped together in the blood leading to the formation of a clot or thrombus. Factors facilitating the growth of the platelet aggregation devices market are worldwide growing older population coupled with rising prevalence of target diseases, surging number of industry-academia collaborations and clinical studies, and growth in technological developments pertaining to platelet aggregometers. However, the presence of unfavorable healthcare reforms in the US and procedural limitations are anticipated to limit the market growth over the forecast period. The World Health Organization (WHO) reported that the worldwide population aged 60 years and above was 962.0 million in 2017, which is projected to increase to over 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.


Segmentation


The global platelet aggregation devices market has been segmented into product, application, and end user.


By product, the market has been segmented into systems, reagents, and consumables and accessories. In 2017, the systems segment dominated the market due to continuous technological advancements in sensors and detectors, increasing automation of platelet aggregation testing procedures, and growing adoption and market preference for automated instruments among diagnostic laboratories


On the basis of application, the market has been divided into clinical applications and research applications. The clinical applications segment is further divided into cardiovascular applications, orthopedic applications, and others.


 Based on end user, the market has been categorized into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.


The global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The platelet aggregation devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European platelet aggregation devices market has been segmented into Western Europe and Eastern Europe. The Western Europe platelet aggregation devices market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The platelet aggregation devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The platelet aggregation devices market in the Middle East & Africa has been segmented into the Middle East and Africa.


 Regional Market Summary


 Global Platelet Aggregation Devices Market Share (%), by Region, 2017


Platelet Aggregation Devices Market


Source: White Papers, Company Presentations, Annual Reports


Geographically, in 2017, the Americas led the global platelet aggregation devices market due to the presence of device manufacturers, surging number of surgical procedures, growing awareness among healthcare professionals (HCPs) about the benefits offered by platelet aggregation testing in disease diagnosis, and significant investments in R&D activities which utilize platelets. For instance, according to the National Center for Health Statistics, in 2009, about 48.0 million surgical inpatient procedures were performed in the US, which grew to 1.54 million in the year end 2017.


The availability of affordable platelet function tests and expanding distribution channels, surging number of cardiovascular surgeries, new technological developments in platelet aggregators, and increase in number of clinical studies in the UK, Germany, and France is expected to support the second largest position of Europe in the global market. For instance, as per the data published by the European Medicines Agency (EMA) and the British Medical Journal, approximately 4,000 clinical trials of medicines are authorized annually in the European Union (EU).


The market in Asia-Pacific would witness the fastest growth during the forecast period attributed to growing geriatric population coupled with rising prevalence of chronic diseases, increasing adoption of new technological devices, and rising incidences of mosquito-borne diseases, namely, malaria and dengue. According to the World Health Organization, severe dengue is a leading cause of serious illness and death among children in some Asian and Latin American countries. More than 40.0% of the world’s population in more than 100 countries are at risk of dengue infection. The most significant dengue epidemics in recent years have occurred in Southeast Asia, the Americas and the Western Pacific. An estimated 390.0 million dengue infections occur across the globe every year.


The platelet aggregation devices market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023 owing to adoption of novel technologies, rising prevalence of hemophilia disease, improving healthcare infrastructure, and expansion of business by various market players in Gulf Cooperation Council (GCC) countries, Israel, and South Africa.


Global Platelet Aggregation Devices Market, by Product



  • Systems

  • Reagents

  • Consumables and Accessories


Global Platelet Aggregation Devices Market, by Application



  • Clinical Applications

    • Cardiovascular Applications

    • Orthopedic Applications

    • Others



  • Research Applications


Global Platelet Aggregation Devices Market, by End User



  • Hospitals and Clinics

  • Diagnostic Laboratories

  • Research and Academic Institutes

  • Others


Global Platelet Aggregation Devices Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Platelet Aggregation Devices Market, by Key Players



  • Siemens Healthineers

  • Hoffmann-La Roche Ltd

  • Sentinel CH. SpA

  • Sysmex Corporation

  • Werfen

  • Helena Laboratories

  • Bio/Data Corporation

  • Haemonetics Corporation

  • AggreDyne, Inc.

  • Haemochrom Diagnostica GmbH

  • Pathway Diagnostics Limited


Intended Audience



  • Platelet aggregation devices manufacturers/suppliers

  • Traders, distributors, wholesalers, retailers, importers and exporters

  • Venture capitalists

  • Contract research organizations (CROs)

  • Association and government bodies

  • Market research and consulting service providers

  • Hospitals and clinics

  • Diagnostic laboratories

  • Research and academic institutes

  • Corporate entities



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: USD 215.2 Million
  CAGR   2017-2023: 20.3%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Siemens Healthineers, Hoffmann-La Roche Ltd, Sentinel CH. SpA, Sysmex Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, Haemonetics Corporation, AggreDyne, Haemochrom Diagnostica GmbH, Pathway Diagnostics Limited,
  Key Market Opportunities   Healthcare infrastructure, and expansion of business
  Key Market Drivers   The rising prevalence of hematological diseases is the major driver for the market.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


The platelet aggregation devices market was valued at USD 215.2 million in 2017.

The global platelet aggregation devices market is expected to exhibit a strong 20.3% CAGR over the forecast period from 2018 to 2023.

The rising prevalence of hematological diseases is the major driver for the market.

The Americas dominate the global platelet aggregation devices market.

Leading players in the market include Siemens, Werfen, Haemonetics Corporation, AggreDyne Inc., and Sysmex, among others.

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

4.6. Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

Chapter 6. Global Platelet Aggregation Devicesby Product

6.1. Introduction

6.2. Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Consumables and Accessories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Platelet Aggregation Devicesby Application

7.1. Introduction

7.2. Clinical Applications

7.2.1. Cardiovascular Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Orthopedic Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Research Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Platelet Aggregation Devices Market, by End User

8.1. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2. Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Research and Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Platelet Aggregation Devicesby Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Siemens Healthineers

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financials Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. F. Hoffmann-La Roche Ltd

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financials Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Sentinel CH. SpA

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financials Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Sysmex Corporation

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financials Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Werfen

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financials Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Helena Laboratories

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financials Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Bio/Data Corporation

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financials Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Haemonetics Corporation

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financials Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. AggreDyne, Inc.

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financials Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Haemochrom Diagnostica GmbH

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financials Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Pathway Diagnostics Limited

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financials Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s View point

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Platelet Aggregation Devices Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Platelet Aggregation Devices Synopsis, 2020-2027

Table 2. Global Platelet Aggregation Devices Estimates and Forecast, 2020-2027 (USD Million)

Table 3. Global Platelet Aggregation Devices by Region, 2020-2027 (USD Million)

Table 4. Global Platelet Aggregation Devices by Product, 2020-2027 (USD Million)

Table 5. Global Platelet Aggregation Devices by Application, 2020-2027 (USD Million)

Table 6. Global Platelet Aggregation Devices by End User, 2020-2027 (USD Million)

Table 7. North America: Platelet Aggregation Devices Market, by Product, 2020-2027 (USD Million)

Table 8. North America: Platelet Aggregation Devices Market, by Application, 2020-2027 (USD Million)

Table 9. North America: Platelet Aggregation Devices Market, by End User, 2020-2027 (USD Million)

Table 10. US: Platelet Aggregation Devices Market, by Product, 2020-2027 (USD Million)

Table 11. US: Platelet Aggregation Devices Market, by Application, 2020-2027 (USD Million)

Table 12. US: Platelet Aggregation Devices Market, by End User, 2020-2027 (USD Million)

Table 13. Canada: Platelet Aggregation Devices Market, by Product, 2020-2027 (USD Million)

Table 14. Canada: Platelet Aggregation Devices Market, by Application, 2020-2027 (USD Million)

Table 15. Canada: Platelet Aggregation Devices Market, by End User, 2020-2027 (USD Million)

Table 16. Latin America: Platelet Aggregation Devices Market, by Product, 2020-2027 (USD Million)

Table 17. Latin America: Platelet Aggregation Devices Market, by Application, 2020-2027 (USD Million)

Table 18. Latin America: Platelet Aggregation Devices Market, by End User, 2020-2027 (USD Million)

Table 19. Europe: Platelet Aggregation Devices Market, by Product, 2020-2027 (USD Million)

Table 20. Europe: Platelet Aggregation Devices Market, by Application, 2020-2027 (USD Million)

Table 21. Europe: Platelet Aggregation Devices Market, by End User, 2020-2027 (USD Million)

Table 22. Western Europe: Platelet Aggregation Devices by Product, 2020-2027 (USD Million)

Table 23. Western Europe: Platelet Aggregation Devices by Application, 2020-2027 (USD Million)

Table 24. Western Europe: Platelet Aggregation Devices by End User, 2020-2027 (USD Million)

Table 25. Eastern Europe: Platelet Aggregation Devices by Product, 2020-2027 (USD Million)

Table 26. Eastern Europe: Platelet Aggregation Devices by Application, 2020-2027 (USD Million)

Table 27. Eastern Europe: Platelet Aggregation Devices by End User, 2020-2027 (USD Million)

Table 28. Asia-Pacific: Platelet Aggregation Devices by Product, 2020-2027 (USD Million)

Table 29. Asia-Pacific: Platelet Aggregation Devices by Application, 2020-2027 (USD Million)

Table 30. Asia-Pacific: Platelet Aggregation Devices by End User, 2020-2027 (USD Million)

Table 31. Middle East & Africa: Platelet Aggregation Devices by Product, 2020-2027 (USD Million)

Table 32. Middle East & Africa: Platelet Aggregation Devices by Application, 2020-2027 (USD Million)

Table 33. Middle East & Africa: Platelet Aggregation Devices by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Platelet Aggregation Devices Market

Figure 3. Segmentation Market Dynamics for Global Platelet Aggregation Devices Market

Figure 4. Global Platelet Aggregation Devices Market Share, by Product, 2020

Figure 5. Global Platelet Aggregation Devices Market Share, by Application, 2020

Figure 6. Global Platelet Aggregation Devices Market Share, by End User, 2020

Figure 7. Global Platelet Aggregation Devices Market Share, by Region, 2020

Figure 8. North America: Platelet Aggregation Devices by Country, 2020

Figure 9. Europe: Platelet Aggregation Devicesby Country, 2020

Figure 10. Asia-Pacific: Platelet Aggregation Devices Market Share, by Country, 2020

Figure 11. Middle East & Africa: Platelet Aggregation Devices, by Country, 2020

Figure 12. Global Platelet Aggregation Devices Market: Company Share Analysis, 2020 (%)

Figure 13. Siemens Healthineers: Key Financials

Figure 14. Siemens Healthineers: Segmental Revenue

Figure 15. Siemens Healthineers: Geographical Revenue

Figure 16. F. Hoffmann-La Roche Ltd: Key Financials

Figure 17. F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 18. F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 19. Sentinel CH. SpA: Key Financials

Figure 20. Sentinel CH. SpA: Segmental Revenue

Figure 21. Sentinel CH. SpA: Geographical Revenue

Figure 22. Sysmex Corporation: Key Financials

Figure 23. Sysmex Corporation: Segmental Revenue

Figure 24. Sysmex Corporation: Geographical Revenue

Figure 25. Werfen: Key Financials

Figure 26. Werfen: Segmental Revenue

Figure 27. Werfen: Geographical Revenue

Figure 28. Helena Laboratories: Key Financials

Figure 29. Helena Laboratories: Segmental Revenue

Figure 30. Helena Laboratories: Geographical Revenue

Figure 31. Bio/Data Corporation: Key Financials

Figure 32. Bio/Data Corporation: Segmental Revenue

Figure 33. Bio/Data Corporation: Geographical Revenue

Figure 34. Haemonetics Corporation: Key Financials

Figure 35. Haemonetics Corporation: Segmental Revenue

Figure 36. Haemonetics Corporation: Geographical Revenue

Figure 37. AggreDyne, Inc.: Key Financials

Figure 38. AggreDyne, Inc.: Segmental Revenue

Figure 39. AggreDyne, Inc.: Geographical Revenue

Figure 40. Haemochrom Diagnostica GmbH: Key Financials

Figure 41. Haemochrom Diagnostica GmbH: Segmental Revenue

Figure 42. Haemochrom Diagnostica GmbH: Geographical Revenue

Figure 43. Pathway Diagnostics Limited: Key Financials

Figure 44. Pathway Diagnostics Limited: Segmental Revenue

Figure 45. Pathway Diagnostics Limited: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.